Search company, investor...

AnaMar Medical

Founded Year



Other Investors | Alive

About AnaMar Medical

AnaMar Medical is a company in the field of cartilage biology and associated joint diseases. The company has an project portfolio with five drugs and one biomarker in development and two biomarkers on the market.

Headquarters Location

Kungsportsavenyn 22



Missing: AnaMar Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: AnaMar Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

AnaMar Medical Patents

AnaMar Medical has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Chess openings, Collagens, Immune system, Proteins, Immunology


Application Date


Grant Date



Related Topics

Chess openings, Collagens, Immune system, Proteins, Immunology



AnaMar Medical Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

AnaMar Medical Rank

AnaMar Medical Frequently Asked Questions (FAQ)

  • When was AnaMar Medical founded?

    AnaMar Medical was founded in 1998.

  • What is AnaMar Medical's latest funding round?

    AnaMar Medical's latest funding round is Other Investors.

  • Who are the investors of AnaMar Medical?

    Investors of AnaMar Medical include Koncentra Verkstads and Linkmed.

  • Who are AnaMar Medical's competitors?

    Competitors of AnaMar Medical include Evotec SE, Rigel Pharmaceuticals, Acetylon Pharmaceuticals, Marinus Pharmaceuticals, Koronis Pharmaceuticals and 12 more.

Compare AnaMar Medical to Competitors


MuriGen is building a portfolio of drugs for unmet medical needs across a number of therapeutic areas including cancer, arthritis, thrombocytopenia, inflammation, epilepsy and thalassemia.

Can-Fite BioPharma Logo
Can-Fite BioPharma

Can-Fite BioPharma is a biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities.


PROTEOLOGICS develops a class of drugs for viral and other ubiquitin-mediated diseases utilizing technology and knowledge of the ubiquitin system.

Virdante Pharmaceuticals

Virdante Pharmaceuticals is developing safer and more effective drugs for autoimmune and inflammatory diseases. The company's products incorporate a proprietary sialic switch technology to improve the anti-inflammatory properties of antibodies.


LaGray is engaged in the research and development of drugs for the treatment of endemic diseases in Sub-Saharan Africa.


Inverseon Overview There are over 20 million Americans living with asthma -- and the numbers continue to increase. Inverseon, Inc. is a clinical-stage company developing drugs for chronic diseases of the lung. Inverseon's asthma program has successfully completed two Phase IIa proof-of-concept human studies

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.